Cystadenocarcinoma, Serous

Known as: Cystadenocarcinoma, Serous [Disease/Finding], serous carcinoma, Serous Cystadenocarcinomas 
A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1939-2018
010020019392017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
The biology of ovarian carcinoma differs from that of hematogenously metastasizing tumors because ovarian cancer cells primarily… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The objective of this study was to identify and characterize a self-renewing subpopulation of human ovarian tumor cells (ovarian… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Proposed origins of pelvic serous carcinoma include the ovary, fallopian tube, and peritoneum. Prophylactic salpingo… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The tubal fimbria is a common site of origin for early (tubal intraepithelial carcinoma or TIC) serous carcinomas in women with… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE We evaluated the efficacy and safety of bevacizumab in patients with platinum-resistant epithelial ovarian carcinoma (EOC… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
A proportion of adenocarcinomas in prophylactic adnexectomies (bilateral salpingo-oophorectomies [BSOs]) from women with BRCA… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The infrequent association of serous borderline tumors (SBTs) with invasive serous carcinoma has led to the view that SBTs are… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
In this study, we evaluate a two-tier system for grading ovarian serous carcinoma. This system is based primarily on the… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Activating mutations in KRAS and in one of its downstream mediators, BRAF, have been identified in a variety of human cancers. To… (More)
  • figure 1
Is this relevant?
Highly Cited
1989
Highly Cited
1989
Microcystic cystadenoma of the pancreas is a well-recognized although rare pathological entity. All previously reported examples… (More)
Is this relevant?